Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of NPAS2 mRNA | decreases expression | 19933214
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NPAS2 mRNA | decreases expression | 19150397
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of NPAS2 mRNA | decreases expression | 20678512
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of NPAS2 mRNA | affects expression | 17484886
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in decreased expression of NPAS2 mRNA | decreases expression | 16934159
|
D004610 |
Ellagic Acid |
Ellagic Acid results in increased expression of NPAS2 mRNA | increases expression | 12002526
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NPAS2 mRNA | affects binding|increases activity|increases expression | 19710929
|
C059514 |
resveratrol |
resveratrol results in increased expression of NPAS2 mRNA | increases expression | 12002526 12569576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NPAS2 mRNA | decreases expression | 19933214
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NPAS2 mRNA | increases expression | 20159946
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 14514962 15322242 11752688 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
4.06 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.42 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.87 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.87 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.60 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.62 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.38 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17264841 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.07 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.57 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.92 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
1.92 | 17651959 17534123 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.04 | 16050911 15700767 15673190 16011737 15721981 16124888 18705752 16192424 16227642 3786805 10355542 16097048 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.27 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
3.27 | 16227395 19321006 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.27 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.88 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
2.76 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.61 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.86 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.39 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.48 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.87 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.94 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
4.14 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.62 | 15027814 16227642 3786805 9327722 7179309 19085960 4309450 10092053 3732212 21278145 15998439 10915739 6623471 2869522 19336974 7440962 6884620 16177239 17522070 15968718 7120509 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
6.62 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.62 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.66 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
12.66 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.66 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.26 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
5.11 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
8.37 | 12795759 16045604 19224547 17595544 12631006 16239168 15959796 61145 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.37 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
9.47 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.47 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.83 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.14 | 18467677 19176532 16221962 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.14 | 15340226 12621046 16120746 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.46 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.82 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.21 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.25 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.35 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.50 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.91 | 17600658 |
MESH:D007249 |
Inflammation |
|
resveratrol |
5.39 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.39 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.86 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.74 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.74 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.70 | 16087638 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.91 | 11408273 21278145 17157831 16239168 16943688 11903743 17334410 17174718 16221502 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.50 | 14620537 18395914 18481824 18277467 17640975 17761835 16638106 12546737 15959796 15730626 15925388 12586293 17766677 12666154 14716833 14716496 15650968 12649538 15057751 17823541 18705752 15673190 15876570 18376398 18187930 17481882 18156304 18251166 18420326 17708605 11481614 12958196 15370692 12632514 14724832 12898905 15893842 12741479 15052691 17557913 18418968 16136751 18205269 14748882 16033810 15818738 17631135 17714472 16116963 18412020 17922224 15338365 18054572 17805973 18395095 15996030 12632512 17869086 16027843 18472332 17976157 18210741 20821823 18472094 16097048 16248980 18429990 16015684 18317297 12667390 17944888 17900296 18166357 16192424 10355542 17565644 17698563 17721639 15931870 12445421 14512876 18263696 18339082 18006644 13678700 18279442 12609069 17525996 15123356 15362042 12389079 16011737 12445418 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.50 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.50 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.12 | 15830285 16964402 15720792 17285989 16246199 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.42 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.88 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
11.27 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.27 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
11.27 | 19812893 19073162 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.27 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
6.16 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.16 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.52 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
4.04 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.53 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.23 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
resveratrol |
2.39 | 17992120 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.58 | 17112576 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.61 | 17935668 16267019 14749477 16490592 17049120 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.16 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.99 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.99 | 17188708 17015251 16525036 16456233 16317513 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.56 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.56 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
5.04 | 17322642 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.03 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.26 | 8985016 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.39 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.39 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.98 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.62 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.48 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.27 | 11985600 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
18.04 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
18.04 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
18.04 | 11896295 11222880 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.41 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.42 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.42 | 17804756 15767336 17675339 16731767 17636462 17718901 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.07 | 10548101 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.90 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.87 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.87 | 15827377 16314181 16317513 17520802 17058453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
6.00 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.00 | 16192470 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.67 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.27 | 16684133 16045194 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.41 | 16227395 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.29 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.33 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.37 | 17044934 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.56 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |